DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm

The owner of DIAGOMICS has sold the company to ZytoMax GmbH.

Founded in 2009 by Gwénola Tanneau and based in Blagnac, France, DIAGOMICS is a specialized retailer of oncology reagents for in-vitro diagnosis for laboratories, hospitals, clinics and research centers in France, Belgium, Luxemburg, Switzerland, Spain, Tunisia and Morocco. With a highly qualified technical service, the highest level of quality control and an optimal quality-price ratio, DIAGOMICS is recognized as an independent reference in the value-added distribution of support reagents to in-vitro diagnosticians.

Structured in 2021 by Archimed, a global investment firm focused on the healthcare industries, ZytoMax brings together the expertise of three companies, ZytoMed, ZytoVision and 42Life Sciences. Based in Berlin, Germany, ZytoMax specializes in the development, manufacture and distribution of diagnostic reagents and system solutions for immunohistology, in-situ hybridization and molecular pathology. The company employs more than 110 people throughout Europe.

Oaklins’ team in France advised DIAGOMICS, a distributor of oncology reagents, on its affiliation with ZytoMax GmbH.

Services

Vente d'entreprise

Parties prenantes

«DIAGOMICS has reached a strategic turning point given its rapid and exponential growth. To strengthen our market position and continue to offer innovative and quality products, DIAGOMICS is joining the ZytoMax group. Our shared values, such as scientific expertise and customer proximity, contributed to this choice.»

Gwénola Tanneau

Founder and CEO, DIAGOMICS

Contacter l'équipe de la transaction

Xavier Auvergnat

Associé

Toulouse, France
Oaklins France

Voir le profil Entrer en contact

Théo Cavalière

Analyste

Toulouse, France
Oaklins France

Voir le profil Entrer en contact

Transactions connexes

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Soins de la Santé

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

En apprendre plus

He-Man Dual Controls has been acquired by Lagercrantz UK Limited

Placements Privés | Automobile | Machinerie Industrielle et Composantes

He-Man Dual Controls has been acquired by Lagercrantz UK Limited

Lagercrantz UK Limited has acquired 100% of the shares in HM Holding Limited (He-Man Dual Controls), a leader in supplemental control systems for vehicles.

En apprendre plus

All Glass & Windows has been recapitalized by Cross Rapids Capital

Placements Privés | Construction et Ingénierie

All Glass & Windows has been recapitalized by Cross Rapids Capital

Prospect Partners has sold All Glass & Windows (AGW) to Cross Rapids Capital.

En apprendre plus